Erythema Clinical Trial
Official title:
Efficacy Study of a Novel Cosmetic Product to Reduce an UVB Induced Erythema
Verified date | April 2023 |
Source | Amazentis SA |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The aim of this study is to determine the erythema-reducing efficacy of a test product in two concentrations on a light sunburn induced by a sun simulator compared to an untreated control and a placebo product.
Status | Completed |
Enrollment | 22 |
Est. completion date | April 13, 2022 |
Est. primary completion date | March 31, 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility | Inclusion Criteria: - Written Informed Consent to participate in the study - Willingness to actively participate in the study and to come to the scheduled visits - Female and/or male - From 18 to 65 years of age - Uniform skin color and no erythema or dark pigmentation in the test area - ITA° > 28 in the test area Exclusion Criteria: - Female subjects: Pregnancy or lactation - Drug addicts, alcoholics - AIDS, HIV-positive or infectious hepatitis - Conditions which exclude a participation or might influence the test reaction/evaluation - Participation or being in the waiting period after participation in cosmetic and/or pharmaceutical studies pertaining to the test area - One of the following illnesses with reduced physical capability/fitness: asthma (symptom-free allergic asthma is not an exclusion criterion), hypertension, cardiovascular diseases - Cancer not being diagnosed as cured and requiring chemotherapy, irradiation and/or hormonal treatment within the last 2 years - Insulin-dependent diabetes mellitus - Electronic implant (e.g. pace maker, insulin pump, hearing aid, and the like) that cannot be removed during irradiation - Documented allergies to cosmetic products and/or ingredients - Active skin disease at the test area - Irregularly tanned skin in the test area - Medical history of dysplastic nevi, melanoma or other skin carcinoma - Medical history of abnormal response to sunlight - Regular use of tanning beds (more than 10 times within the last 6 months) - Wounds, moles, tattoos, scars, irritated skin, excessive hair growth, etc. at the test area that could influence the investigation - Usage of medication with known photo-toxic and/or photo-sensitizing potential (e.g. some antibiotics, blood pressure regulating agents and antidepressants agents; hypericum perforatum) within the last 14 days prior to the start of the study and/or throughout the entire course of the study - Any topical medication at the test area within the last 7 days prior to the start of the study and/or throughout the entire course of the study - Systemic therapy with immuno-suppressive drugs (e.g. corticosteroids) and/or antihistamines (e.g. antiallergics) within the last 7 days prior to the start of the study and/or throughout the entire course of the study - Systemic therapy with anti-phlogistic agents or analgetics (e.g. diclophenac), except for minor pain relief medicine like acetylsalicylic acid or paracetamol within the last 3 days prior to the start of the study and/or throughout the entire course of the study |
Country | Name | City | State |
---|---|---|---|
Germany | proderm GmbH | Schenefeld |
Lead Sponsor | Collaborator |
---|---|
Amazentis SA | proDERM GmbH |
Germany,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Erythema (skin redness) assessed by Chromameter | 3 days | ||
Primary | Visual erythema evaluation by a trained grader on a scale of -2 (marked redness) to 3 (no redness) | 3 days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT04290273 -
Characterisation of the Time-course Response of UV-induced Erythema
|
N/A | |
Completed |
NCT01659853 -
Efficacy and Safety Study Comparing CD07805/47 Gel 0.5% to Azelaic Acid Gel 15% in Subjects With Erythema of Rosacea
|
Phase 3 | |
Completed |
NCT00839462 -
Efficacy of Dexpanthenol in Thermic Erythema
|
Phase 2 | |
Not yet recruiting |
NCT06016361 -
Evaluation of a Novel Amino Acid Based Moisturizing Cream as Part of the Daily Standard Skincare Regimen Recommended During Radiation Therapy
|
N/A | |
Completed |
NCT03633877 -
Durapore vs. Hy-Tape to Secure The Endotracheal Tube
|
N/A | |
Active, not recruiting |
NCT02876107 -
Carboplatin and Paclitaxel With or Without Panitumumab in Treating Patients With Invasive Triple Negative Breast Cancer
|
Phase 2 | |
Completed |
NCT06369675 -
Skin Irritation Potential of MOB015B in Healthy Subjects Using a Cumulative Irritant Patch Test Design
|
Phase 1 | |
Completed |
NCT03352323 -
An Evaluation of the Reduction in Erythema in Adult Patients With Moderate to Severe Persistent Facial Erythema Associated With Rosacea
|
Phase 3 | |
Completed |
NCT06369727 -
Study to Evaluate the Sensitizing Potential of MOB015B in Healthy Subjects Using a Repeat Insult Patch Test Design
|
Phase 1 | |
Completed |
NCT03041064 -
Multiday Beach Study
|
N/A | |
Completed |
NCT02832141 -
Effect of Thoracic Spine Mobilization on Sympathetic Nervous Systems
|
||
Completed |
NCT02131636 -
Efficacy and Safety of AGN-199201 in Patients With Persistent Erythema Associated With Rosacea
|
Phase 3 | |
Completed |
NCT01636765 -
Study of Inter- and Intra-rater Reliability of the Clinician Erythema Assessment Scale
|
||
Terminated |
NCT01597921 -
A DB Randomized Study of R1 and R2 WaterJel / AloeVera Jell in Prevention of Radiation Dermatitis in Breast Cancer
|
N/A | |
Completed |
NCT01124513 -
Melanin Index in Those With Fitzpatrick Skin Phototypes I-VI
|
N/A | |
Terminated |
NCT03496584 -
Effects of Phytonutrients on Vascular Health and Skin in Obese Males
|
N/A | |
Completed |
NCT02737592 -
A Clinical Study to Evaluate the Safety of a Personal Lubricant in Healthy Female Subjects
|
N/A | |
Completed |
NCT03852563 -
A Study to Gain Information How Well Dexpanthenol Derma Cream Helps the Face Skin to Recover After Cosmetic Lasering
|
N/A | |
Completed |
NCT03477825 -
Pilot Study of Triphala and Rubia Cordifolia on Gut Microbiome and Skin
|
N/A | |
Completed |
NCT02490943 -
A Pilot Study of Warm and Cold Compress to Reduce Injection Site Erythema Due to Peginterferon-beta-1a in MS
|
N/A |